Gilead Sciences, Inc. (NASDAQ:GILD)’s traded shares stood at 1.84 million during the latest session, with the company’s beta value hitting 0.23. At the last check today, the stock’s price was $66.51, to imply an increase of 0.53% or $0.35 in intraday trading. The GILD share’s 52-week high remains $87.86, putting it -32.1% down since that peak but still an impressive 0.92% since price per share fell to its 52-week low of $65.90. The company has a valuation of $82.94B, with an average of 7.41 million shares over the past 3 months.
Gilead Sciences, Inc. (NASDAQ:GILD) trade information
After registering a 0.53% upside in the latest session, Gilead Sciences, Inc. (GILD) has traded red over the past five days. The 5-day price performance for the stock is -2.29%, and -10.09% over 30 days. With these gigs, the year-to-date price performance is -17.90%.
Gilead Sciences, Inc. (GILD) estimates and forecasts
Looking at statistics comparing Gilead Sciences, Inc. share performance against respective industry, we note that the company has underperformed competitors. Gilead Sciences, Inc. (GILD) shares are -16.51% down over the last 6 months, with its year-to-date growth rate lower than industry average at -2.53% against 13.30%.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 1.55% for the past 5-year period. While 2024 is set for a 5.91% return in earnings, projections for the next 5 years are at 5.05% annually.
GILD Dividends
Gilead Sciences, Inc. has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Gilead Sciences, Inc. has a forward dividend ratio of 3.02, with the share yield ticking at 4.54% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
